Cercare il medicinale per il nome

Serax e Convulsioni

Risultato del controllo d'interazione tra il farmaco Serax e la malattia Convulsioni su sicurezza in caso d'uso simultaneo.

Risultato di controllo:

Serax <> Convulsioni

Rilevanza: 23.07.2019 Recensore: P.M. Shkutko, dott., in

Durante il controllo d'interazione, secondo le fonti autorevoli Drugs.com, Rxlist.com, Webmd.com, Medscape.com sono trovate le controindicazioni o gli effetti collaterali che possono danneggiare oppure intensificare l’effetto negativo in caso d'uso del farmaco in presenza di questa malattia concomitante.

Consumatore:

L'uso di benzodiazepine in pazienti con disturbi convulsivi possono aumentare l'incidenza o precipitare l'insorgenza di generalizzate tonico-cloniche (grande male). Appropriato, anticonvulsive farmaco potrebbe aver bisogno di essere avviato o il dosaggio è aumentato. La brusca cessazione della terapia di benzodiazepine può precipitare crisi epilettiche e altri sintomi di astinenza, soprattutto dopo un uso prolungato e/o a dosaggi eccessivi. Stato di male epilettico può verificarsi in pazienti con una storia di convulsioni ritirata rapidamente dalla terapia di benzodiazepine. A seguito di somministrazione cronica, la cessazione della terapia di benzodiazepine dovrebbe avvenire gradualmente in modo incrementale con dosaggi ridotti. I pazienti devono essere avvisati di non interrompere il farmaco senza aver prima consultato il medico.

Fonte

Berlin RM, Conell LJ "Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: a case report." Am J Psychiatry 140 (1983): 488-90
Tien AY, Gujavarty KS "Seizure following withdrawal from triazolam." Am J Psychiatry 142 (1985): 1516-7
Browne JL, Hauge KJ "A review of alprazolam withdrawal." Drug Intell Clin Pharm 20 (1986): 837-41
"Product Information. Doral (quazepam)." Wallace Laboratories, Cranbury, NJ.
"Product Information. ProSom (estazolam)." Abbott Pharmaceutical, Abbott Park, IL.
"Product Information. Versed (midazolam)." Roche Laboratories, Nutley, NJ.
"Product Information. Dalmane (flurazepam)." Roche Laboratories, Nutley, NJ.
MacKinnon GL, Parker WA "Benzodiazepine withdrawal syndrome: a literature review and evaluation." Am J Drug Alcohol Abuse 9 (1982): 19-33
"Product Information. Valium (diazepam)." Roche Laboratories, Nutley, NJ.
Busto U, Sellers EM, Naranjo CA, et al "Withdrawal reaction after long-term therapeutic use of benzodiazepines." N Engl J Med 315 (1986): 854-9
Roy-Byrne PP, Sullivan MD, Cowley DS, Ries RK "Adjunctive treatment of benzodiazepine discontinuation syndromes - a review." J Psychiatr Res 27 Suppl (1993): 143-53
Petursson H, Lader MH "Benzodiazepine dependence." Br J Addict 76 (1981): 133-45
Howe JG "Lorazepam withdrawal seizures." Br Med J 280 (1980): 1163-4
Ghadirian AM, Gauthier S, Wong T "Convulsions in patients abruptly withdrawn from clonazepam while receiving neuroleptic medication ." Am J Psychiatry 144 (1987): 686
Bond WS, Schwartz M "Withdrawal reactions after long-term treatment with flurazepam." Clin Pharm 3 (1984): 316-8
"Product Information. Serax (oxazepam)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Halcion (triazolam)." Pharmacia and Upjohn, Kalamazoo, MI.
Wilbur R, Kulik AV "Abstinence syndrome from therapeutic doses of oxazepam." Can J Psychiatry 28 (1983): 298-300
Hersch EL, Billings RF "Acute confusional state with status petit mal as a withdrawal syndrome: and five year follow-up." Can J Psychiatry 33 (1988): 157-9
Robinson GM, Sellers EM "Diazepam withdrawal seizures." Can Med Assoc J 126 (1982): 944-5
Schneider LS, Syapin PJ, Pawluczyk S "Seizures following triazolam withdrawal despite benzodiazepine treatment." J Clin Psychiatry 48 (1987): 418-9
"Product Information. Xanax (alprazolam)." Pharmacia and Upjohn, Kalamazoo, MI.
"Product Information. Klonopin (clonazepam)." Roche Laboratories, Nutley, NJ.
Finley PR, Nolan PE, Jr "Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam." DICP 23 (1989): 151-2
Kales A, Bixler EO, Soldatos CR, Jacoby JA, Kales JD "Lorazepam: effects on sleep and withdrawal phenomena." Pharmacology 32 (1986): 121-30
Hauser P, Devinsky O, De Bellis M, Theodore WH, Post RM "Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders." Arch Neurol 46 (1989): 696-9
Ryan GP, Boisse NR "Experimental induction of benzodiazepine tolerance and physical dependence." J Pharmacol Exp Ther 226 (1983): 100-7
Ananth J "Abstinence syndrome from therapeutic doses of oxazepam." Can J Psychiatry 28 (1983): 592
"Product Information. Tranxene (clorazepate)." Abbott Pharmaceutical, Abbott Park, IL.
"Product Information. Librium (chlordiazepoxide)." Roche Laboratories, Nutley, NJ.
"Product Information. Ativan (lorazepam)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Frattola L, Garreau M, Piolti R, Bassi S, Albizzati MG, Borghi C, Morselli PL "Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients." Br J Psychiatry 165 (1994): 94-100
Alvarez N, Hartford E, Doubt C "Epileptic seizures induced by clonazepam." Clin Electroencephalogr 12 (1981): 57-65
Specht U, Boenigk HE, Wolf P "Discontinuation of clonazepam after long-term treatment." Epilepsia 30 (1989): 458-63
Patterson WM "Triazolam withdrawal." J Clin Psychiatry 49 (1988): 369
"Product Information. Restoril (temazepam)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.